Ketamine shows promise for rapid relief of suicidal ideation

NCT ID NCT02299440

Completed Symptom relief Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether ketamine, given as two infusions, can quickly reduce suicidal thoughts in 156 hospitalized patients at high risk for suicide. The main goal was to see if suicidal ideas resolved within 24 hours after the second dose. The approach aims to provide fast, short-term relief during a crisis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUICIDAL IDEATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Suicidal Ideation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SUICIDAL IDEATION

Contacts and locations

Locations

APHP - Hôpital Lariboisière

Paris, 75010, France
CHRU de Lille - Hôpital Michel Fontan

Lille, 59037, France
CHRU de Montpellier - Hôpital Lapeyronie

Montpellier, 34295, France
CHRU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, 30029, France
CHRU de Tours - Clinique Psychiatrique Universitaire

Saint-Cyr-sur-Loire, 37540, France
CHU de Clermont Ferrand - Hôpital Gabriel-Montpied

Clermont-Ferrand, 63003, France
CMME Centre Hospitalier Sainte Anne

Paris, 75674, France
Centre Hospitalier Sainte-Anne

Paris, 75674, France
Clinique Les Sophoras

Nîmes, 30000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.